Список литературы

Поставить закладку

Davidoff A.M. Wilms’ tumor // Current Opinion in Pediatrics. Curr Opin Pediatr, 2009. Vol. 21, № 3. P. 357–364.
Rivera M.N., Haber D.A. Wilms’ tumour: Connecting tumorigenesis and organ development in the kidney // Nature Reviews Cancer. Nature Publishing Group, 2005. Vol. 5, № 9. P. 699–712.
Buckley K.S. Pediatric genitourinary tumors. // Curr. Opin. Oncol. 2011. Vol. 23, № 3. P. 297– 302.
Beckwith J.B., Kiviat N.B., Bonadio J.F. Nephrogenic rests, nephroblastomatosis, and the pathogenesis of wilms’ tumor // Fetal Pediatr. Pathol. Informa Healthcare, 1990. Vol. 10, № 1–2. P. 1–36.
Breslow N.E. et al. Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor // Pediatr. Blood Cancer. 2006. Vol. 47, № 3. P. 260–267.
Gadd S. et al. A Children’s Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor // Nat. Genet. Nature Publishing Group, 2017. Vol. 49, № 10. P. 1487– 1494.
Szychot E., Apps J., Pritchard-Jones K. Wilms’ tumor: biology, diagnosis and treatment. // Transl. Pediatr. AME Publications, 2014. Vol. 3, № 1. P. 12–24.
Szychot E., Brodkiewicz A., Pritchard-Jones K. Review of Current Approaches to the Management of Wilms’ Tumor // Int. J. Clin. Rev. Remedica Medical Education and Publishing, 2012.
Chu A. et al. Wilms’ tumour: A systematic review of risk factors and meta-analysis // Paediatric and Perinatal Epidemiology. 2010. Vol. 24, № 5. P. 449–469.
Spreaﬁco F., Bellani F.F. Wilms’ tumor: Past, present and (possibly) future // Expert Review of Anticancer Therapy. Expert Rev Anticancer Ther, 2006. Vol. 6, № 2. P. 249–258.
Beckwith J.B. National Wilms Tumor Study: An update for pathologists // Pediatr. Dev. Pathol. Springer, 1998. Vol. 1, № 1. P. 79–84.
Green D.M. Wilms’ Tumor // Diagnosis and Management of Malignant Solid Tumors in Infants and Children. Springer US, 1985. P. 129–186.
Scott R.H. et al. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour // Journal of Medical Genetics. BMJ Publishing Group, 2006. Vol. 43, № 9. P. 705– 715.
Sandoval J.A., Malkas L.H., Hickey R.J. Clinical signiﬁcance of serum biomarkers in pediatric solid mediastinal and abdominal tumors // Int. J. Mol. Sci. MDPI AG, 2012. Vol. 13, № 1. P. 1126– 1153.
Magee F. et al. Neural differentiation in Wilms’ tumor. // Hum. Pathol. 1987. Vol. 18, № 1. P. 33–37.
Детская онкология. Национальное руководство. Под ред. М.Д. Алиева, В.Г. Полякова, Г.Л. Менткевича, С.А. Маяковой. М.: Издательская группа РОНЦ. Практическая медицина, 2012. 684 p.
Zamperlini-Netto G. et al. PO-60 - Renal tumors with extensive vascular disease: management challenges in a pediatric series from the Hospital for Sick Children. // Thromb. Res. 2016. Vol. 140 Suppl 1. P. S198-9.
Kebudi R. et al. Seroprevalence of hepatitis b, hepatitis c, and hiv in children with cancer at diagnosis and following therapy in turkey: Progress within the last 25 years // Turk Pediatr. Ars. AVES, 2019. Vol. 54, № 2. P. 82–85.
Riccabona M. Imaging of renal tumours in infancy and childhood // European Radiology. 2003. Vol. 13, № SUPPL. 4.
Grundy P.E. et al. Clinical signiﬁcance of pulmonary nodules detected by CT and Not CXR in patients treated for favorable histology Wilms tumor on national Wilms tumor studies-4 and -5: A report from the Children’s Oncology Group // Pediatr. Blood Cancer. 2012. Vol. 59, № 4. P. 631–635.
Smets A.M.J.B. et al. The contribution of chest CT-scan at diagnosis in children with unilateral Wilms’ tumour. Results of the SIOP 2001 study // Eur. J. Cancer. Eur J Cancer, 2012. Vol. 48, № 7. P. 1060–1065.
Stanescu A.L. et al. Pediatric Renal Neoplasms:: MR Imaging–Based Practical Diagnostic Approach // Magnetic Resonance Imaging Clinics of North America. W.B. Saunders, 2019. Vol. 27, № 2. P. 279–290.
Voss S.D. Staging and following common pediatric malignancies: MRI versus CT versus functional imaging // Pediatric Radiology. Springer Verlag, 2018. Vol. 48, № 9. P. 1324–1336.
Massin M.M. et al. Acute arrhythmogenicity of ﬁrst-dose chemotherapeutic agents in children // Med. Pediatr. Oncol. 2002. Vol. 39, № 2. P. 93–98.
Blatt J. et al. Pilot study of cardiac function after treatment of childhood wilms’ tumor with doxorubicin // Pediatr. Hematol. Oncol. Informa Healthcare, 1995. Vol. 12, № 1. P. 61–66.
Agarwala S. et al. High incidence of adriamycin cardiotoxicity in children even at low cumulative doses: Role of radionuclide cardiac angiography // J. Pediatr. Surg. W.B. Saunders, 2000. Vol. 35, № 12. P. 1786–1789.
Durrant J.D. et al. American Academy of Audiology Position Statement and Clinical Practice Guidelines: Ototoxicity Monitoring Task Force Members. 2009.
Brooks B., Knight K. Ototoxicity monitoring in children treated with platinum chemotherapy // Int. J. Audiol. Taylor and Francis Ltd, 2018. Vol. 57, № sup4. P. S34–S40.
Vujanić G.M. et al. The role of biopsy in the diagnosis of renal tumors of childhood: Results of the UKCCSG Wilms Tumor Study 3 // Med. Pediatr. Oncol. Wiley-Liss Inc., 2003. Vol. 40, № 1. P. 18–22.
Ünal E. et al. Twenty children with non-wilms renal tumors from a reference center in central anatolia, Turkey // Turkish J. Med. Sci. Turkiye Klinikleri, 2020. Vol. 50, № 1. P. 18–24.
August D.A., Huhmann M.B. A.S.P.E.N. Clinical guidelines: Nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation // Journal of Parenteral and Enteral Nutrition. JPEN J Parenter Enteral Nutr, 2009. Vol. 33, № 5. P. 472–500.
Васильева Е.С., Вашура А.Ю., Литвинов Д.В. Нутритивный статус детей с онкологическими и гематологическими заболеваниями, находящихся на лечении в ФГБУ «ФНКЦ ДГОИ им. Дмитрия Рогачева» (результаты скринингового исследования) // Современная онкология. 2016. Vol. 18, № 4. P. 48–52.
Isenring E., Elia M. Which screening method is appropriate for older cancer patients at risk for malnutrition? // Nutrition. Elsevier Inc., 2015. Vol. 31, № 4. P. 594–597.
Martin L. et al. Diagnostic criteria for the classiﬁcation of cancer-associated weight loss // J. Clin. Oncol. American Society of Clinical Oncology, 2015. Vol. 33, № 1. P. 90–99.
Manary M.J., Sandige H.L. Management of acute moderate and severe childhood malnutrition // BMJ. BMJ, 2008. Vol. 337, № 7680. P. 1227–1230.
van den Broeck J., Eeckels R., Massa G. Validity of Single-Weight Measurements to Predict Current Malnutrition and Mortality in Children // J. Nutr. 1996. Vol. 126, № 1. P. 113–120.
Meijers J.M.M. et al. Nutritional care; do process and structure indicators inﬂuence malnutrition prevalence over time? // Clin. Nutr. Churchill Livingstone, 2014. Vol. 33, № 3. P. 459– 465.
Muscaritoli M. et al. Consensus deﬁnition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) “ cachexia-anorexia in chronic wasting diseases” and “ nutrition in geriatrics” // Clin. Nutr. Clin Nutr, 2010. Vol. 29, № 2. P. 154–159.
Kondrup J. et al. ESPEN guidelines for nutrition screening 2002 // Clin. Nutr. Churchill Livingstone, 2003. Vol. 22, № 4. P. 415–421.
Arends J. et al. ESPEN guidelines on nutrition in cancer patients // Clin. Nutr. Churchill Livingstone, 2017. Vol. 36, № 1. P. 11–48.
Van Den Heuvel-Eibrink M.M. et al. Position Paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol // Nat. Rev. Urol. Nature Publishing Group, 2017. Vol. 14, № 12. P. 743–752.
Kieran K., Ehrlich P.F. Current surgical standards of care in Wilms tumor // Urologic Oncology: Seminars and Original Investigations. Elsevier Inc., 2016. Vol. 34, № 1. P. 13–23.
Israels T. et al. The efﬁcacy and toxicity of SIOP preoperative chemotherapy in Malawian children with a Wilms tumour // Pediatr. Blood Cancer. 2012. Vol. 59, № 4. P. 636–641.
Fuchs J. et al. Surgical aspects in the treatment of patients with unilateral wilms tumor: A report from the SIOP 93-01/German society of pediatric oncology and hematology // Ann. Surg. 2009. Vol. 249, № 4. P. 666–671.
Elgendy A. et al. National Survey on the Management of Wilms Tumor // J. Pediatr. Hematol. Oncol. Lippincott Williams and Wilkins, 2019. Vol. 41, № 4. P. 280–285.
Cox S., Büyükünal C., Millar A.J.W. Surgery for the complex Wilms tumour // Pediatr. Surg. Int. Springer, 2020. Vol. 36, № 2. P. 113–127.
Alkazemi M.H. et al. Partial and radical nephrectomy in children, adolescents, and young adults: Equivalent readmissions and postoperative complications // J. Pediatr. Surg. W.B. Saunders, 2019. Vol. 54, № 11. P. 2343–2347.
Walker J.P. et al. Factors affecting lymph node sampling patterns and the impact on survival of lymph node density in patients with Wilms tumor: a Surveillance, Epidemiology, and End Result (SEER) database review // J. Pediatr. Urol. Elsevier Ltd, 2019.
Godzinski J., Graf N., Audry G. Current concepts in surgery for Wilms tumor-the risk and function-adapted strategy // European Journal of Pediatric Surgery. Georg Thieme Verlag, 2014. Vol. 24, № 6. P. 457–460.
Varlet F. et al. Laparoscopic treatment of renal cancer in children: A multicentric study and review of oncologic and surgical complications // J. Pediatr. Urol. Elsevier Ltd, 2014. Vol. 10, № 3. P. 500–505.
Varlet F. et al. Laparoscopic radical nephrectomy for unilateral renal cancer in children // Surg. Laparosc. Endosc. Percutaneous Tech. Lippincott Williams and Wilkins, 2009. Vol. 19, № 2. P. 148–152.
Kieran K. et al. Repeat nephron-sparing surgery for children with bilateral Wilms tumor // J. Pediatr. Surg. J Pediatr Surg, 2014. Vol. 49, № 1. P. 149–153.
Godzinski J. The current status of treatment of Wilms’ tumor as per the SIOP trials // Journal of Indian Association of Pediatric Surgeons. Medknow Publications, 2014. Vol. 20, № 1. P. 16–20.
Israels T. et al. SIOP PODC: Clinical guidelines for the management of children with Wilms tumour in a low income setting // Pediatr. Blood Cancer. 2013. Vol. 60, № 1. P. 5–11.
Pritchard J. et al. Results of the United Kingdom Children’s Cancer Study Group ﬁrst Wilms’ tumor study // J. Clin. Oncol. J Clin Oncol, 1995. Vol. 13, № 1. P. 124–133.
Mitchell C. et al. The treatment of Wilms’ tumour: Results of the United Kingdom Children’s Cancer Study Group (UKCCSG) second Wilms’ tumour study // Br. J. Cancer. Churchill Livingstone, 2000. Vol. 83, № 5. P. 602–608.
Green D.M. et al. Effect of duration of treatment on treatment outcome and cost of treatment for Wilms’ tumor: A report from the National Wilms’ Tumor Study Group // J. Clin. Oncol. American Society of Clinical Oncology, 1998. Vol. 16, № 12. P. 3744–3751.
Dome J.S. et al. Treatment of anaplastic histology Wilms’ tumor: Results from the ﬁfth National Wilms’ Tumor Study // J. Clin. Oncol. J Clin Oncol, 2006. Vol. 24, № 15. P. 2352–2358.
Malogolowkin M. et al. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the national Wilms tumor study group // Pediatr. Blood Cancer. Pediatr Blood Cancer, 2008. Vol. 50, № 2. P. 236–241.
UMBRELLA Protocol SIOP-RTSG 2016 [Electronic resource]. 2016. P. 336. URL: http://www.fnkc.ru/docs/SIOP-RTSG2016.pdf.
Owens C.M. et al. Bilateral disease and new trends in Wilms tumour // Pediatric Radiology. Pediatr Radiol, 2008. Vol. 38, № 1. P. 30–39.
Hamilton T.E. et al. The management of synchronous bilateral wilms tumor: A report from the National Wilms Tumor Study Group // Ann. Surg. Ann Surg, 2011. Vol. 253, № 5. P. 1004–1010.
Sudour H. et al. Bilateral Wilms tumors (WT) treated with the SIOP 93 protocol in France: Epidemiological survey and patient outcome // Pediatr. Blood Cancer. Pediatr Blood Cancer, 2012. Vol. 59, № 1. P. 57–61.
Indolﬁ P. et al. Synchronous bilateral Wilms tumor: A report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) // Cancer. Cancer, 2013. Vol. 119, № 8. P. 1586–1592.
Joosten K.F.M., Kerklaan D., Verbruggen S.C.A.T. Nutritional support and the role of the stress response in critically ill children // Current Opinion in Clinical Nutrition and Metabolic Care. Lippincott Williams and Wilkins, 2016. Vol. 19, № 3. P. 226–233.
Koletzko B. et al. Guidelines on Paediatric Parenteral Nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), Supported by the European Society of Paediatri // Journal of Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr, 2005. Vol. 41, № SUPPL. 2. 87 p.
Tanner L. et al. Cancer Rehabilitation in the Pediatric and Adolescent/Young Adult Population // Seminars in Oncology Nursing. Elsevier Inc, 2020. Vol. 36, № 1. P. 150984.
Oken M.M. et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group // Am. J. Clin. Oncol. 1982. Vol. 5, № 6. P. 649–655.
SB L. et al. The Measurement of Performance in Childhood Cancer Patients // Cancer. Cancer, 1987. Vol. 60, № 7.